Kalytera Therapeutics (OTC: KALTF) PERFORMANCE ANALYSIS IN FOCUS:
Volatility or average true range percent (ATRP 14) is 20%. The ATR expressed as a percentage of closing price. Average true range percent (ATRP) volatility on a relative level. ATRP allows securities to be compared whereas ATR does not. Lower-priced stocks will not lower
Kalytera Therapeutics (OTC: KALTF) has performed -32.25% around last month and performed -32.25% over the last quarter. The stock showed return of -88.708333% over five years and registered weekly return of 8.4%. Return stock last twelve months.
Tracking last 52 weeks, the stock 52 week high price observed at $ 0.4544 and 52 week low seen at $ 0. The 50 SMA is $ 0.070358 and 200 SMA is $ 0.090816. Moving in can be used as support or resistance in the market. This can also be said in the following way. In the case of the moving average on the price chart, the trader will be looking into a short position. Actually, this works in the same way as the horizontal support or resistance lines. Dynamic support and resistance, simply because they tend to change with prices.
Kalytera Therapeutics (OTC: KALTF) stock has changed $ 0.0022 and moved 4.23% or stock price touched at $ 0.0542 in the last trading session. 162608 shares exchanged at hands while it's an average volume stands with 246542 shares. The company recorded relative volume of 0.66. Volume is most important for traders. Heavily-traded stocks allow investors to trade quickly and easily, without dramatically changing the price of the stock. If you are not so many buyers or sellers at any given time, then buyers and sellers may be interested in ordering to make a trade.
.
EBITDA is $ -4784000. EBITDA is a company's earnings before interest, with a company's net earnings, before interest expenses, depreciation and amortization are subtracted, as a proxy for a company's current operating profitability.
Net Income of the company is $ -21382000. Net Income Available for Common Shareholders equals net income minus preferred dividends paid. Net income available to the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is less all expenses and preferred dividends. The number of joint action plans on the company's cash flows.
Return on capital employed (ROCE) is -7.84%. Return on capital employed (ROCE) is a financial ratio that measures a company's profitability and efficiency with which its capital is used. Return on capital employed (ROCE) is the total amount of capital that has been used in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets.
The current ratio is 0.221. The current ratio is the classic measure of liquidity. It means whether the business can pay two years within one year out of the current assets. The quick ratio is 0.221. 1: 1 shows the business can meet its current financial obligations with quick funds on hand. A ratio lower than 1: 1 may indicate that the company relies too much on inventory or other assets to pay its short-term liabilities.
The debt / equity shows a value of 59.26. D / E Ratio is calculated by dividing a company's total liabilities by its shareholder equity. In general, a high debt-to-equity ratio indicates that it can not generate sufficient debt to satisfy its debt obligations. However, low debt-to-equity ratios may also indicate that a company is not taking advantage of the increased profits that financial leverage may bring.
PROFITABILITY RATIOS:
Tracking profitability check, the firm profit margin which was recorded at 0.00%. The Company has been able to maintain return on assets (ROA) at -15.01% for the last twelve months. Return on equity (ROE) recorded at -191.57%.
VALAATION OBSERVATIONS:
Headquarters Location of Kalytera Therapeutics (OTC: KALTF) is United States. P / B ratio is 1.793104. P / B is used to appear as stock market value at its book value. It has a market cap of $ 14193037. Using market capitalization to show the size of a company is important because the company is a basic determinant of various characteristics in which investors are interested, including risk.
TECHNICAL INDICATORS:
Now The company has RSI figures of 35.28. RSI compares the magnitude of recent gains to recent losses. RSI is plotted on a scale of 0-100. Generally, if it is above 70, the stock is deemed to be overbought and so on. Similarly, an RSI of less than 30 says the stock is oversold and can be bought.
ADX value listed at 30.55. ADX indicator measures strong or weak trends. This can be either a strong uptrend or a strong downtrend. It does not tell you if the trend is up or down. If ADX is between 0 and 25 then the stock is in a trading range. It is likely just chopping around sideways. Avoid these weak, pathetic stocks! Once ADX gets above 25 then you will begin to see the beginning of a trend. Big moves up or down) tend to happen when ADX is right around this number. / P>
When the ADX indicator gets above 30 then you are staring at a strong trend! These are the stocks that you want to be trading! You will not find very many stocks with the ADX above 50. Once it gets that high, you start to see trends coming to an end and trading.
David Culbreth – Category – Business
David Culbreth is a self-taught investor who has been investing in equities since he was a senior in college and continues to invest. He is extremely devoted to demystifying investing terminology for new investors.
David Culbreth is a senior author and journalist. He has more than 5 years of experience in institutional investment markets, including fixed income, equities, derivatives and real estate. David has a Bachelor in Business Administration with a major in Finance. He bought his first stock in a private business at the age of 15 and made his first public stock exchange at 23. He has been interested in the stock market and how it behaves.
He is made of money saving and investing for them at high priority. Over many years of investing, he has made some wise choices and he has made many mistakes. But he's learned from both. Mr. David observations and experience give the insight to the market and the investor behaviors that create them.
